TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
China shares have had their worst October in a decade, and the sell-off yesterday was the larg...
T Rowe Price's Chris Alderson explains why stock market performance is diverging - and what in...
Trying to time the stock market will only result in capital loss says Morningstar Investment M...
VIDEO: In his Q4 market outlook, Michael Field profiles some undervalued European energy, consume...
Is this the under-discussed reason active fund managers are struggling to outperform?
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Alternative energy and ESG themes are declining in popularity among investors, but the shift to a...
Despite possible benefits from the election, Tesla stock looks overvalued.
Candriam Sustainable Equity US and M&G North American Dividend Fund are among the sustainable fun...
UPDATED: Xtrackers MSCI Europe Information Technology ESG Screened UCITS ETF and iShares Global C...
In its Q3 2024 earnings results, pharmaceutical stock confirmed the next payout of 15p to be paid...
Adam Fleck, CFA Adam Fleck is an associate director of research with Morningstar.